drugs – IMMpress Magazine

Feature

The Development and Advances in Treatments for Autoimmune Diseases

Sarah ColpittsDecember 20, 2021December 19, 2021

Health care is rapidly evolving. From new ways to harness the immune system’s natural capabilities to advances in nanotechnology and the advent of omics and big data, we are continuously...

Feature

Small vs Big: Understanding the Differences between Small Molecule Drugs and Biologic Drugs

Helen WangAugust 19, 2019August 18, 2019

Small molecule drugs make up 90% of global drug sales in today’s pharmaceutical market. In the past decade, newly emerging classes of drugs, including biologics and biosimilars, are increasingly gaining...

Feature

Trials and Errors: The Use of Social Media in Clinical Trials

Christina DitlofAugust 19, 2019August 19, 2019

Based on statistics recorded in 2019 by the Canadian Internet Registration Authority, 60% of Canadians report to use social media platforms. The term ‘social media’ encompasses internet and electronic based...

Feature

Weighing the Risks: Regulating Pharmaceuticals

Sarah ColpittsAugust 19, 2019August 19, 2019

Regulatory affairs is a blanket term for the processes that regulate industries. The pharmaceutical and medical device industries, energy sector, and banking, among others, all work within the confines of...

Feature

Orphan Drugs & Diseases

Salma Sheikh-MohamedAugust 19, 2019August 19, 2019

In the 1960s, the United States congress passed the “Drug Efficacy Amendment”, which introduced for the first time a requirement for pharmaceutical companies to disclose side effects and dangers of...

Feature

The Opioid Crisis

Dario FerriJuly 20, 2018July 20, 2018

In the beginning, it killed the pain and it didn’t bother me. I didn’t have cravings for it or anything like that. When I couldn’t stand the pain, I would...

Feature

Puff or Pass? How Marijuana’s Legalization May Help Manage Chronic Pain Among Canadians

Ellinore DoroshenkoJuly 20, 2018July 15, 2018

Whether it's smoked, eaten or vaporized, marijuana consumption in humans leads to some fairly predictable outcomes: euphoria, hunger, relaxation, introspection, nervousness and even paranoia. Increasingly, however, people are consuming the plant for another...

Feature

Tripping out of Depression: Overcoming Mental Health Disorders with Psychedelic Drugs

Pailin ChiaranuntJuly 20, 2018July 15, 2018

You’re in a hut in the jungle, the music of wildlife and aroma of smoking herbs permeating the air. The shaman, dressed in traditional Amazonian garb, hands you the brownish...

Feature Grad Life Perspective

Buck Up or Get Out: U of T’s New Mandatory Leave Policy Sends the Wrong Message about Mental Health

Kieran ManionJuly 20, 2018July 15, 2018

THE PREMISE For many young adults, university is the first time they are forced to contend with their mental health. Being away from friends and family, losing the security of a structured high...

Cover

Issue 2 2018 – Front Cover

Kieran Manion and Angela ZhouJuly 20, 2018July 15, 2018

The 1960s was a revolutionary decade that turned traditional Western norms on their heads. Consumerism culture was growing, spurred by the emergence of television, and a “generation gap” was dividing...

Tag: drugs

The Development and Advances in Treatments for Autoimmune Diseases

Small vs Big: Understanding the Differences between Small Molecule Drugs and Biologic Drugs

Weighing the Risks: Regulating Pharmaceuticals

Orphan Drugs & Diseases

The Opioid Crisis

Puff or Pass? How Marijuana’s Legalization May Help Manage Chronic Pain Among Canadians

Tripping out of Depression: Overcoming Mental Health Disorders with Psychedelic Drugs

Buck Up or Get Out: U of T’s New Mandatory Leave Policy Sends the Wrong Message about Mental Health

Issue 2 2018 – Front Cover

Recent Comments

Sponsors